Skip to main navigation
Skip to search
Skip to main content
Rutgers, The State University of New Jersey Home
Help & FAQ
Link opens in a new tab
Search content at Rutgers, The State University of New Jersey
Home
Profiles
Research units
Core Facilities
Federal Grants
Research output
Host blood RNA signatures predict the outcome of tuberculosis treatment
the Catalysis TB–Biomarker Consortium
New Jersey Medical School (NJMS), Medicine, Division of Infectious Disease
Institute for Quantitative Biomedicine (IQB)
Research output
:
Contribution to journal
›
Article
›
peer-review
138
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Host blood RNA signatures predict the outcome of tuberculosis treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tuberculosis Treatment
100%
Treatment Failure
100%
TB Treatment
100%
Blood RNA
100%
MiRNA Signature
100%
Correlates of Risk
50%
Treatment Initiation
25%
Clinically Significant
25%
RNA Sequencing (RNA-seq)
25%
Active Tuberculosis
25%
Latent Tuberculosis Infection
25%
New Therapies
25%
Transcriptome
25%
Host Response
25%
Novel Host
25%
Tuberculosis Treatment Outcomes
25%
Inflammatory State
25%
Drug Therapy
25%
Individualized Treatment
25%
Patients at Risk
25%
Quantitative PCR
25%
Host Gene Expression
25%
Positron Emission Tomography-computed Tomography (PET-CT)
25%
Patient Stratification
25%
TB Disease
25%
Sputum
25%
GeneXpert
25%
Mitochondrial Genes
25%
Whole Blood
25%
PCR-based
25%
5-gene Signature
25%
Disease Signature
25%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
RNA
100%
RNA Sequence
100%
Immune Response
100%
Positron Emission Tomography-Computed Tomography
100%
Mitochondrial Gene
100%
Real-Time Polymerase Chain Reaction
100%
Gene Signature
100%
Transcriptome
100%
Drug Therapy
100%
Immunology and Microbiology
RNA Sequence
100%
Immune Response
100%
Gene Expression
100%
Transcriptome
100%
Positron Emission Tomography-Computed Tomography
100%
Sputum
100%
Real Time Polymerase Chain Reaction
100%
Mitochondrial Gene
100%
Drug Therapy
100%
Neuroscience
Gene Expression
100%
Positron Emission Tomography-Computed Tomography
100%
Transcriptome
100%
RNA Sequence
100%
Real-Time Polymerase Chain Reaction
100%
Mitochondrial Gene
100%
Drug Therapy
100%
Medicine and Dentistry
Tuberculosis Treatment
100%
Diseases
100%
Biological Marker
66%
Drug Therapy
33%
Tuberculosis
33%
Gene Expression
33%
Immune Response
33%
RNA Sequence
33%
Transcriptome
33%
Positron Emission Tomography-Computed Tomography
33%
Sputum
33%
Real Time Polymerase Chain Reaction
33%
Identified Patient
33%
Mitochondrial Gene
33%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Biological Marker
66%
Tuberculosis
33%
Pharmacotherapy
33%
Transcriptome
33%
RNA-Sequencing
33%
Polyethylene Terephthalate
33%